[optimal] Re: Perpetual Fluorescein Angiography Consents

  • From: Eric Kegley <ekegley@xxxxxxxxxxxxxxxxx>
  • To: "optimal@xxxxxxxxxxxxx" <optimal@xxxxxxxxxxxxx>
  • Date: Mon, 19 Feb 2018 23:05:30 +0000

Ian,

I believe our consent states this, but I consent subjects every time I do an FA 
on them. I don’t want there to be any question that I reviewed risks with the 
patient.

Thanks,
EK

[cid:image001.png@01D3A9A3.D6EDABE0]Eric Kegley, CRA, OCT-C, FOPS,  COA
Director of Ophthalmic Imaging
Retina Consultants of Houston
6560 Fannin St., Suite 750
Houston, TX 77030
Main  713 524-3434
Direct   713 394-7531
Fax      713 524-3220
www.houstonretina.com<http://www.houstonretina.com/>
www.facebook.com/RetinaConsultantsofHouston<http://www.facebook.com/RetinaConsultantsofHouston>

From: optimal-bounce@xxxxxxxxxxxxx [mailto:optimal-bounce@xxxxxxxxxxxxx] On ;
Behalf Of Ian Ryan
Sent: Monday, February 19, 2018 4:47 PM
To: optimal@xxxxxxxxxxxxx
Subject: [optimal] Perpetual Fluorescein Angiography Consents

Optimal,
Any thoughts on AAO and OMIC's informed consents which have embedded perpetual 
FA clauses? Are there sites out there that have this in place?


https://www.aao.org/Assets/a2d9a6b3-423e-42c5-8d90-225e6111631c/635514157803170000/fluorescein-angiography-pdf
"For patients who need repeat FAs, the consent is valid until it is either 
revoked by the patient or the patient’s condition changes to the point that the 
risks and benefits are significantly different."


https://www.omic.com/wp-content/uploads/2012/12/Fluorescein-Angiography-RMRL-01242008.pdf
"This consent will be valid until I revoke it or my condition changes to the 
point that the risks and benefits of this procedure for me are significantly 
different."


Best,

Ian Ryan, Research Photographer
Northern California Retina Vitreous Associates (NCRVA)
2485 Hospital Drive, Suite 200, Mountain View, CA 94040
Direct: (650) 962-5934 | Main: (650)988-7467 | Fax: (650) 962-5786 | Fax: (650) 
966-9307
iryan@xxxxxxxxx<mailto:iryan@xxxxxxxxx>

PNG image

Other related posts:

  1. Home
  2. optimal
  3. Archive
  4. 02-2018